Transformative Research & Leadership Development
Our interdisciplinary teams discover, design, and disseminate cost-saving innovations for conditions comprising the bulk of U.S. health care spending. We collaborate closely with research, industry, and philanthropic partners.
Harnessing Innovations Across Medicine, Engineering, and Management
Care Model Innovations
Following a rigorous, standardized process, CERC research teams have developed scalable delivery innovations that lower spending while improving outcomes.
Research
CERC’s interdisciplinary teams focus on Care Delivery Innovations, Health Care Policy, Computer Vision, Machine Learning, Process Innovation, and Organizational Innovation.
Published Research and CERC in the News
Through published research and articles, CERC is shaping the national discourse around value-based care delivery, health policy and reform, and AI-based innovations.
Health Care Policy
CERC faculty offer a deep examination of systemic issues in the health care system largely unaddressed by other research groups.
The Power of Computer Vision in Health Care
Our AI innovations support care delivery in the ICU, improve hand hygiene and surgical technique in clinical settings, and enhance the well-being of seniors living at home.
Collaboration Opportunities
CERC offers industry and research partners numerous opportunities to shape high-quality, lower cost patient care alongside noted Stanford scholars and innovators.
Training Healthcare Leaders Who Innovate Technology and Business Designs
The New Master of Science in Clinical Informatics Management
This one-year management program for working professionals - the first of its kind on the West Coast - will provide leaders and emerging leaders in health care and technology with the clinical business and informatics capabilities to transfrom care delivery through digital innovation. Applications for the Class of 2022 will be available in September 2020.
CERC’s Design, Innovation and Clinical Entrepreneurship (DICE) Fellowship
CERC’s 11-month Design Fellowship provides early-career innovators and aspiring health care leaders the opportunity to gain the knowledge, skills, and experience to design care delivery innovations that result in better care at lower cost.
Executive Education Led by Distinguished CERC Scholars
We offer clinicians, researchers, and executives a dynamic learning environment in which to identify, develop, and implement technology and management innovations that reduce the cost of great care.
Recent News & Publications
– JAMA NetworkSurgical Outcomes After Implementation of a Medicare Pay-for-Performance Program
This cross-sectional study examines the outcomes of Medicare patients who underwent surgery before and after implementation of the Hospital-Acquired Conditions Present on Admission program.
– BMJ Global HealthNovel strategies to support global promotion of COVID-19 vaccination
In this new paper, CERC’s Kevin Schulman asserts that consumer marketing practices in the US can boost Covid-19 vaccination rates globally – if they are adapted to local cultures.
– New England Journal of MedicineEarly Convalescent Plasma for High-Risk Outpatients with Covid-19
Original Article from The New England Journal of Medicine — Early Convalescent Plasma for High-Risk Outpatients with Covid-19
– NEJM GroupLeading Health Care Teams Beyond Covid-19: Marking the Moment and Shifting from Recuperation to Regeneration
How health care leaders can guide their teams to a post-pandemic state that is even better than before.
– IEEE XploreSmart Home Technologies Are Saving Money and Lives
Smart home technologies, designed to make users happier, healthier, and wealthier, are rapidly becoming a mainstay of everyday life. In most cases, signal processing is essential to the devices' operation and performance.
– New York TimesOur drug supply is sick. How can we fix it?
CERC’s Kevin Schulman: “The free market simply isn’t working for generic drugs.”
– Stanford News Center5 Questions: Kevin Schulman on whether taxpayers should pay for controversial new Alzheimer’s drug
CERC’s Kevin Schulman weighs in on the likely impact of the FDA’s approval of Aduhelm.